Highly experienced with GLP-1 receptor agonists
In the SURPASS-2 study, tirzepatide 15 mg resulted in a faster and greater decline in body weight ( 5.5 kg) compared to semaglutide 1.0 mg, more than doubling the proportion of patients achieving at least 10% weight loss (57% vs 24%) [3]
Moon B, Takaki S, Miyake K, Takatsu K
Your personalized program may include nutritional counseling, dietary modifications, exercise recommendations, behavioral coaching, and in some cases, prescription medications or medically supervised treatments designed to boost metabolism or control appetite
Results May Vary: Individual weight loss results vary based on factors including age, baseline weight, consistency of medication adherence, diet and exercise changes, genetic factors, current medications, underlying health conditions, and other individual variables
After accounting for weight loss, the researchers found that in the semaglutide group, being older, female or eating less protein was linked to greater muscle loss